Business Context and Reporting Period
This Form 8-K filing by Immunocore Holdings Plc (IMCR) reports on events occurring on December 31, 2024, and January 2, 2025. The primary disclosure concerns the appointment of a new Chief Financial Officer and the resignation of a board member.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and personnel changes.
Material Changes
The material change reported is the appointment of Travis Coy as Executive Vice President, Chief Financial Officer, and Head of Corporate Development, effective January 1, 2025. Concurrently, Mr. Coy resigned from the Company's Board of Directors.
Management Commentary, Risks, and Unusual Items
Compensation Package:
- Base Salary: $500,000 annually.
- Target Bonus: 40% of base salary ($200,000).
- Sign-on Bonus: $200,000 total, payable in three installments ($100,000 on Jan 31, 2025; $50,000 on Jan 30, 2026; $50,000 on Jan 29, 2027), contingent on continued employment.
- Equity Grant: 274,033 stock options vesting over four years (25% on first anniversary, remainder quarterly).
Severance Provisions:
- Change in Control Period (within 18 months of transaction): 18 months' base salary, 150% of target bonus, pro-rated annual bonus, 18 months COBRA, and full acceleration of unvested equity.
- Outside Change in Control Period: 12 months' base salary and 12 months COBRA.
Risks and Contingencies: The filing notes standard non-disclosure, IP assignment, non-solicitation, and non-competition restrictions. No other financial risks or contingencies are disclosed in this specific report.
Investor Verification Checklist
- Verify the effective date of the CFO appointment (January 1, 2025) and the resignation from the Board.
- Confirm the vesting schedule and exercise terms of the 274,033 option grant.
- Review the upcoming 10-K filing for the full text of the Employment Agreement.
- Monitor the press release (Exhibit 99.1) for additional strategic context regarding the leadership change.